ecteinascidin 743 has been researched along with lometrexol in 1 studies
| Studies (ecteinascidin 743) | Trials (ecteinascidin 743) | Recent Studies (post-2010) (ecteinascidin 743) | Studies (lometrexol) | Trials (lometrexol) | Recent Studies (post-2010) (lometrexol) |
|---|---|---|---|---|---|
| 660 | 102 | 404 | 119 | 7 | 13 |
| Protein | Taxonomy | ecteinascidin 743 (IC50) | lometrexol (IC50) |
|---|---|---|---|
| Trifunctional purine biosynthetic protein adenosine-3 | Homo sapiens (human) | 0.0634 | |
| Trifunctional purine biosynthetic protein adenosine-3 | Mus musculus (house mouse) | 0.78 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, J; Elliott, PJ | 1 |
1 review(s) available for ecteinascidin 743 and lometrexol
| Article | Year |
|---|---|
New agents in cancer clinical trials.
Topics: Antineoplastic Agents; Benzamides; Benzoquinones; Boronic Acids; Bortezomib; Clinical Trials as Topic; Dioxoles; Enzyme Inhibitors; Humans; Hydroxamic Acids; Imatinib Mesylate; Isoquinolines; Lactams, Macrocyclic; Neoplasms; Piperazines; Pyrazines; Pyrimidines; Rifabutin; Stilbenes; Tetrahydrofolates; Tetrahydroisoquinolines; Trabectedin; Vorinostat | 2000 |